AM Margaret Graham

Prof. AM Margaret Graham

Biomedical Sciences, School of Chemistry and Biosciences, University of Bradford, Bradford, UK

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2005 in British Journal of Surgery
Verified
Journal Article
Closed access
PDF file
NBN. R. Banga
N. R. Banga
SHS. Homer‐Vanniasinkam
S. Homer‐Vanniasinkam
AGAM Margaret Graham
AM Margaret Graham
AAA. Al‐Mukhtar
A. Al‐Mukhtar
SWS A White
S A White
KPK. R. Prasad
K. R. Prasad

26 February 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
CBCharlie Bridgewood
Charlie Bridgewood
GFGareth W. Fearnley
Gareth W. Fearnley
ABAnna Berekmeri
Anna Berekmeri
PLPhilip Laws
Philip Laws
TMTom Macleod
Tom Macleod
MWMiriam Wittmann
Miriam Wittmann
The IL-1 family member cytokine IL-36γ is recognised as key mediator in the immunopathology of psoriasis, hallmarks of which involve the activation of both resident and infiltrating inflammatory myeloid cells and aberrant angiogenesis. This research demonstrates a role for IL-36γ in both myeloid activation and angiogenesis. We show that IL-36γ induces the production of psoriasis-associated cytokines from macrophages (IL-23 and TNFα) and that this response is enhanced in macrophages from psoriasis patients. This effect is specific for IL-36γ and could not be mimicked by other IL-1 family cytokines such as IL-1α. IL-36γ was also demonstrated to induce endothelial tube formation and branching, in a VEGF-A-dependent manner. Furthermore, IL-36γ-stimulated macrophages potently activated endothelial cells and led to increased adherence of monocytes, effects that were markedly more pronounced for psoriatic macrophages. Interestingly, regardless of stimulus, psoriasis monocytes showed increased adherence to both the stimulated and unstimulated endothelium when compared with monocytes from healthy individuals. Collectively, these findings show that IL-36γ has the potential to enhance endothelium directed leucocyte infiltration into the skin and strengthen the IL-23/IL-17 pathway adding to the growing evidence of pathogenetic roles for IL-36γ in psoriatic responses. Our findings also point to a cellular response, which could potentially explain cardiovascular comorbidities in psoriasis in the form of endothelial activation and increased monocyte adherence.

1 March 2005 in American Journal of Physiology-Gastrointestinal and Liver Physiology
Verified
Journal Article
Open access
PDF file
JSJoy Carmelina Indira Singh
Joy Carmelina Indira Singh
SCSheena Margaret Cruickshank
Sheena Margaret Cruickshank
DNDarren James Newton
Darren James Newton
LWLouise Wakenshaw
Louise Wakenshaw
AGAM Margaret Graham
AM Margaret Graham
SCSimon Carding
Simon Carding
The interleukin-2-deficient (IL-2−/−) mouse model of ulcerative colitis was used to test the hypothesis that colonic epithelial cells (CEC) directly respond to bacterial antigens and that alterations in Toll-like receptor (TLR)-mediated signaling may occur during the development of colitis. TLR expression and activation of TLR-mediated signaling pathways in primary CEC of healthy animals was compared with CEC in IL-2−/−mice during the development of colitis. In healthy animals, CEC expressed functional TLR, and in response to the TLR4 ligand LPS, proliferated and secreted the cytokines IL-6 and monocyte chemoattractant protein-1 (MCP-1). However, the TLR-responsiveness of CEC in IL-2−/−mice was different with decreased TLR4 responsiveness and augmented TLR2 responses that result in IL-6 and MCP-1 secretion. TLR signaling in CEC did not involve NF-κB (p65) activation with the inhibitory p50 form of NF-κB predominating in CEC in both the healthy and inflamed colon. Development of colitis was, however, associated with the activation of MAPK family members and upregulation of MyD88-independent signaling pathways characterized by increased caspase-1 activity and IL-18 production. These findings identify changes in TLR expression and signaling during the development of colitis that may contribute to changes in the host response to bacterial antigens seen in colitis.

23 March 2015 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
SSSamar A Sultan
Samar A Sultan
WLWanting Liu
Wanting Liu
YPYonghong Peng
Yonghong Peng
WRW. Roberts
W. Roberts
DWDonald Whitelaw
Donald Whitelaw
AGAM Margaret Graham
AM Margaret Graham

1 September 2008 in Atherosclerosis
Verified
Journal Article
Closed access
KEKirstie A. Eccles
Kirstie A. Eccles
HSHeather Sowden
Heather Sowden
KPKaren E. Porter
Karen E. Porter
SPSue M. Parkin
Sue M. Parkin
SHShervanthi Homer-Vanniasinkam
Shervanthi Homer-Vanniasinkam
AGAM Margaret Graham
AM Margaret Graham

1 March 2000 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
AGAlison Graham
Alison Graham
PMPhilip Manning
Philip Manning
CMCalum J. McNeil
Calum J. McNeil
DSDamian Szatkowski
Damian Szatkowski
MTMarina Tsatmali
Marina Tsatmali
ATAnthony J. Thody
Anthony J. Thody